In an animal model, the levels of IL-17 and CCL2 in the liver and intestinal tissues of mice treated with HF+DSS were higher than those of mice treated with HF or DSS alone, and were also found to be related to liver fibrosis (55). The gene discussed is IL17A; the disease is Hepatic fibrosis.